Sinopharm, CoronaVac to be assessed between April 26 and May

Sinopharm, CoronaVac to be assessed between April 26 and May 3: WHO


1
2021-04-10 11:52:30CGTN
Editor : Mo Hong'e
ECNS App Download
Chinese vaccines Sinopharm and CoronaVac (Sinovac) are in the final stage of evaluation by the Emergency Use Listing of the World Health Organization (WHO) and a "final decision" should be made between April 26 and May 3, a WHO official said in a press conference on Friday. 
"We have convened the technical advisory group for a vaccine assessment for the 26th of April," said Rogerio Pinto de Sa Gaspar, director of regulation and prequalification, adding that "at least one of the two" could be evaluated on that date.
The Emergency Use Listing, WHO's internal procedure to assess unlicensed vaccines, is necessary for vaccines to be used under the COVAX Facility, a WHO-led initiative aimed at providing more equitable access to vaccines for low and middle-income countries.

Related Keywords

China , Chinese , Coronavac Sinovac , , Emergency Use Listing , World Health Organization , Rogerio Pinto De Sa Gaspar , சீனா , சீன , அவசரம் பயன்பாடு பட்டியல் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , றோகேரிஓ பிண்டோ டி ச கஸ்பார் ,

© 2025 Vimarsana